Skip to content

IMMUNITYBIO, INC.: filings

Every IMMUNITYBIO, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 45 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-04fiscal Q2 2026421200001326110-26-000079
10-Q2026-05-07fiscal Q1 202648980001326110-26-000059
10-K2026-02-23fiscal FY 2025521360001326110-26-000030
10-Q2025-11-05fiscal Q3 2025501450001326110-25-000139
10-Q2025-08-05fiscal Q2 2025511450001326110-25-000114
10-Q2025-05-12fiscal Q1 2025511040001326110-25-000071
10-K2025-03-03fiscal FY 2024561450001326110-25-000033
10-Q2024-11-12fiscal Q3 2024541560001326110-24-000111
10-Q2024-08-12fiscal Q2 2024531490001326110-24-000103
10-Q2024-05-09fiscal Q1 202449990001326110-24-000064
10-K2024-03-19fiscal FY 2023501370001326110-24-000037
10-Q2023-11-09fiscal Q3 2023491460001326110-23-000147
10-Q2023-08-08fiscal Q2 2023491420001326110-23-000098
10-Q2023-05-11fiscal Q1 2023501020001326110-23-000064
10-K2023-03-01fiscal FY 2022511380001326110-23-000018
10-Q2022-11-09fiscal Q3 2022481400001326110-22-000074
10-Q2022-08-08fiscal Q2 2022491360001326110-22-000058
10-Q2022-05-10fiscal Q1 202247960001326110-22-000027
10-K2022-03-01fiscal FY 2021511400001326110-22-000011
10-Q2021-11-12fiscal Q3 2021491410001326110-21-000009
10-Q2021-08-12fiscal Q2 2021451250001564590-21-044008
10-Q2021-05-14fiscal Q1 202145920001564590-21-028010
10-K2021-03-04fiscal FY 2020451500001564590-21-010945
10-Q2020-11-09fiscal Q3 2020421140001564590-20-052488
10-Q2020-08-07fiscal Q2 2020421140001564590-20-038096
10-Q2020-05-11fiscal Q1 202040820001564590-20-024168
10-K2020-03-25fiscal FY 2019451490001564590-20-012816
10-Q2019-11-05fiscal Q3 2019441190001564590-19-040363
10-Q2019-08-06fiscal Q2 2019451220001564590-19-029330
10-Q2019-05-08fiscal Q1 201944910001564590-19-017179
10-K2019-03-13fiscal FY 2018441490001564590-19-007562
10-Q2018-11-07fiscal Q3 2018431150001564590-18-028007
10-Q2018-08-06fiscal Q2 2018431150001564590-18-019420
10-Q2018-05-07fiscal Q1 201841850001564590-18-011240
10-K2018-03-12fiscal FY 2017411410001564590-18-005290
10-Q2017-11-07fiscal Q3 2017401110001564590-17-022217
10-Q2017-08-07fiscal Q2 2017401110001564590-17-015981
10-Q2017-05-08fiscal Q1 201740830001564590-17-009421
10-K2017-03-15fiscal FY 2016421450001564590-17-004430
10-Q2016-11-10fiscal Q3 2016371010001564590-16-028905
10-Q2016-08-15fiscal Q2 201635920001564590-16-024275
10-Q2016-05-16fiscal Q1 201635690001564590-16-019464
10-K2016-03-30fiscal FY 2015331080001564590-16-015596
10-Q2015-11-12fiscal Q3 201535870001564590-15-010422
10-Q2015-09-10fiscal Q2 201530750001564590-15-007836

Inspect the source

Entity
IMMUNITYBIO, INC. / CIK 0001326110
Captured
2026-09-20T07:52:39.337Z
SEC response SHA-256
d59606b59d6c96ee6b6e8c010479393fd4be764b67f4119ef70d3cefa5bfbc2d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001326110.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))